A study published in the journal Science says that an existing cancer drug appears to improve many of the effects of Alzheimer’s disease in mice.
Researchers in Ohio found the drug bexarotene to be effective in increasing levels of the protein ApoE, which in turn sped up the clearance of amyloid-beta, a hallmark of Alzheimer’s disease. They also discovered that the drug quickly improved memory deficits and behaviour. This supports previous research which has shown that ApoE helps clear amyloid plaques in the brain.
